“Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance”, Mediterr J Hematol Infect Dis, vol. 11, no. 1, p. e2019007, Jan. 2019, doi: 10.4084/mjhid.2019.007.